Company intelligence / Profile preview

500 Global

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

500 Global is an active, independent venture capital firm investing in early- to growth-stage startups (pre-seed to pre-IPO) across technology and innovation sectors worldwide, with a portfolio of 2,600+ companies in 80+ countries. There is no indication it conducts drug development or clinical research itself

Industry: Investors

Partnerships

None specific to biotech or pharma; general partnerships with startups globally.

Beyond the preview

Go deeper on 500 Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 500 Global.

Explore the full profile